Anavex Life Sciences Corp (AVXL)

[TempePhil]

My question is does anyone know what the original context was regarding this?
Bourbon, of course we are pleased that the PDD patients will be able to continue taking 2-73 after the trial.

It is quite common for drug companies, and anavex did this, to offer the drug to all patients after the trial is over. This helps recruitment, as the patients all know they will end up with the drug.
So if the PDD Principal Investigator, asked TGD if his patients could continue getting 2-73 after the trial, like the AD first trial, TGD might have said sure. The PI asked, and TGD can say they the PI asked for continued 2-73 for his patients!
That is very different from the PI noticing lots of patients improving and begging TGD for 2-73 for all the patients after the trial.

You see what I mean? The context is most important!
Can you (or anyone) provide the context?

Thanks